Medical Journals

Oxygen Tension Modulates the Expression of Pulmonary Vascular Bkca Channel Alpha- and Beta-subunits.

Authors:
  • Resnik Ernesto
  • Herron Jean
  • Fu Rao
  • Ivy D Dunbar
  • Cornfield David N

From: Univ. of Minnesota, Minneapolis, MN 55455, USA. resni004@umn.edu

American journal of physiology. Lung cellular and molecular physiology

  • Publish Date: Apr 2006
  • ISSN: 1040-0605
  • Volume: 290
  • Issue: 4
  • Pages: L761-L768
  • Medium: Print
  • Language: English
  • Citation (JAMA): Resnik Ernesto, Herron Jean, Fu Rao, et al. Oxygen Tension Modulates the Expression of Pulmonary Vascular Bkca Channel Alpha- and Beta-subunits.. Am. J. Physiol. Lung Cell Mol. Physiol. Apr 2006;290:L761-L768

Abstract

At birth, the lung environment changes from low to relatively high O(2) tension. Pulmonary blood flow increases and pulmonary artery pressure decreases. Recent data suggest that pulmonary vascular calcium-sensitive K(+) channel (BK(Ca)) activation mediates perinatal pulmonary vasodilation. Although BK(Ca) channel expression is developmentally regulated, the molecular mechanisms responsible for BK(Ca) expression remain unknown. We tested the hypothesis that the low-O(2) tension environment of the normal fetus modulates BK(Ca) channel expression. We analyzed BK(Ca) expression under conditions of hypoxia and normoxia both in vitro and in vivo. BK(Ca) alpha-subunit mRNA expression increased twofold in ovine pulmonary artery smooth muscle cell (PASMC) primary cultures maintained in hypoxia. In vivo, BK(Ca) expression was similarly affected by hypoxia. When adult Sprague-Dawley rats were placed in hypobaric hypoxic chambers for 3 wk, hypoxic animals showed an increase of threefold in the expression of BK(Ca) alpha- and more than twofold in the expression of BK(Ca) beta(1)-subunit mRNA. Immunochemical staining was consistent with the genetic data. To assess transcriptional activation of the beta-subunit of the BK(Ca), both BK(Ca) beta(1)- and beta(2)-subunit luciferase (K(Ca) beta:luc(+)) reporter genes were constructed. Hypoxia increased PASMC K(Ca) beta(1):luc(+) reporter expression by threefold and K(Ca) beta(2):luc(+) expression by 35%. Fetal PASMC treated with the hypoxia-inducible factor-1 mimetic deferoxamine showed a 63 and 41% increase in BK(Ca) channel alpha- and beta(1)-subunit expression, respectively. Together, these results suggest that oxygen tension modulates BK(Ca) channel subunit mRNA expression, and the regulation is, at least in part, at the transcriptional level.

Mesh Headings (Keywords): Animals, Anoxia, Calcium, Cells, Cultured, Deferoxamine, Fetus, Immunohistochemistry, Intracellular Membranes, Large-Conductance Calcium-Activated Potassium Channels, Lung, Myocytes, Smooth Muscle, Osmolar Concentration, Oxygen, Partial Pressure, Peptides, Protein Isoforms, Pulmonary Artery, Rats, Rats, Sprague-Dawley, Sheep, Transcription, Genetic


Check for Full Text / PubMed Unique Identifier (PMID): 16284215


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.